 | Up a level |
Miyamoto, Yuji; Schirripa, Marta; Suenaga, Mitsukuni; Cao, Shu; Zhang, Wu; Okazaki, Satoshi; Berger, Martin D.; Matsusaka, Satoshi; Yang, Dongyun; Ning, Yan; Baba, Hideo; Loupakis, Fotios; Lonardi, Sara; Pietrantonio, Filippo; Borelli, Beatrice; Cremolini, Chiara; Yamaguchi, Toshiharu; Lenz, Heinz-Josef (2020). A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer. PLoS ONE, 15(9), e0239439. Public Library of Science 10.1371/journal.pone.0239439
Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Cremolini, Chiara; Antoniotti, Carlotta; Borelli, Beatrice; Mashima, Tetsuo; Okazaki, Satoshi; Berger, Martin Dave; Miyamoto, Yuji; Gopez, Roel; Barzi, Afsaneh; Lonardi, Sara; Yamaguchi, Toshiharu; Falcone, Alfredo; Loupakis, Fotios and Lenz, Heinz-Josef (2018). Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib. Clinical colorectal cancer, 17(2), e395-e414. Elsevier 10.1016/j.clcc.2018.02.010
Okazaki, Satoshi; Schirripa, Marta; Loupakis, Fotios; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Berger, Martin Dave; Miyamoto, Yuji; Suenaga, Mitsukuni; Iqubal, Syma; Barzi, Afsaneh; Cremolini, Chiara; Falcone, Alfredo; Battaglin, Francesca; Salvatore, Lisa; Borelli, Beatrice; Helentjaris, Timothy G; Lenz, Heinz-Josef (2017). Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Cancer, 123(22), pp. 4506-4514. John Wiley & Sons 10.1002/cncr.30880
Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu; Zhang, Wu; Yang, Dongyun; Dadduzio, Vincenzo; Salvatore, Lisa; Borelli, Beatrice; Pietrantonio, Filippo; Ning, Yan; Okazaki, Satoshi; Berger, Martin Dave; Miyamoto, Yuji; Gopez, Roel; Barzi, Afsaneh; Yamaguchi, Toshiharu; Loupakis, Fotios; Lenz, Heinz-Josef (2017). Potential role of polymorphisms in the transporter genes ENT1 and MATE1/OCT2 in predicting TAS-102 efficacy and toxicity in patients with refractory metastatic colorectal cancer. European journal of cancer, 86, pp. 197-206. Elsevier 10.1016/j.ejca.2017.08.033
